« Switzerland prepares | Main | A German flu blog »

August 22, 2005

Tamiflu versus Relenza

According to a news story in the Australian Courier-Mail, a legal dispute is arising over the marketing of Relenza, an anti-flu drug. Its sales have been small compared to those for Tamiflu, and the creators of Relenza (an Australian biotech firm) claim it's because licencee GlaxoSmithKline didn't market it effectively.

No doubt we'll see such disputes as the stakes get higher.

Posted by dymaxion at August 22, 2005 11:33 AM

Trackback Pings

TrackBack URL for this entry:


Post a comment

Remember Me?